Caplin Point Laboratories Limited has approved its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board recommended a final dividend of ₹4/- per equity share and approved the re-appointment of Dr. Sridhar Ganesan as Managing Director for two years. Additionally, Mr. D. Muralidharan was appointed as Whole-Time Director.
Caplin Point Board Approves Q1 FY27 Financials and Dividend
Caplin Point Laboratories Limited announced today, August 12, 2026, that its Board of Directors has approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The approved results are accompanied by a Limited Review Report and a press release. The company also presented an investor presentation detailing these results.
Dividend Recommendation and Record Date
The Board has recommended a final dividend of ₹4/- (200%) per equity share of ₹2/- each for the financial year ended March 31, 2026. This dividend, subject to shareholder approval at the forthcoming Annual General Meeting (AGM), is expected to be paid on or before October 24, 2026. The Record Date for determining shareholder eligibility for this dividend will be communicated separately to the stock exchanges.
Key Management Appointments Approved
In a significant move for corporate governance, the Board approved the re-appointment of Dr. Sridhar Ganesan (DIN: 06819026) as the Managing Director for a further period of two years, effective from August 25, 2026, to August 24, 2028. This re-appointment is subject to shareholder approval at the upcoming AGM.
Furthermore, Mr. D. Muralidharan (DIN: 08301904) has been appointed as the Whole-Time Director for a period of two years, effective from August 12, 2026, to August 11, 2028. Mr. Muralidharan will continue in his role as the Chief Financial Officer in addition to his new responsibilities.
35th Annual General Meeting Scheduled
The Board also approved the convening of the 35th Annual General Meeting (AGM) of the Company on Friday, September 25, 2026. The AGM will be conducted through Video Conferencing or Other Audio-Visual means.
The board meeting commenced at 10:45 A.M. and concluded at 01:25 P.M. Details regarding changes in Directors, as per SEBI Listing Regulations, are provided in Annexure 5.
Source: BSE
